K562/AO2细胞表面HLAI类分子和MICA/B的表达 NK细胞杀伤活性 参考文献 1栾风君,杨纯正,马建国等.一株红白血病多药耐药细 胞系(K562/AO2)的建立及其耐药特性的研究.中华肿瘤杂志, 1993 正文 作者:**转牛新清郭坤元周健魏红梅 摘要:本研究探讨K562亲本细胞株及多药耐药细胞株 K562/AO2细胞表面HLAI类分子和MHCI类...
The preservation place is China Center for Type Culture Collection. The molecular weight of the HLA-G1 antigen produced by the cell strain is 39 kDa. The HLA-G1 antigen comprises heavy chains, a light chain and antigen peptides. The heavy chains comprise Alpha 1, Alpha 2 and Alpha 3 ...
K562 whole cell lysate(细胞裂解液) 价格电议 起批量≥1 支 最小起订1支 供货总量99999支 发货地址湖北省武汉市 建议售价￥1000/支 更新日期2025年01月14日 产品规格100 μg at 2 mg/ml 即时洽谈立即询价查看联系方式 收藏产品发送留言 VIP3年
beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restrict... Studies of type 1 diabetes indicate that autoaggressive T cells specific to β-cell antigens, reaching certain threshold levels, may ...
Problem: Due to high abundance of decidual CD56+ NK cells in close contact with extravillous trophoblast cells, influence of HLA-G molecule on FasL-mediated cytotoxicity was investigated. Methods of study: Decidual mononuclear cells were isolated by density gradient and decidual lymphocytes were collec...
Articles Basic Science Investigation nature publishing group Early tissue transglutaminase–mediated response underlies K562(S)-cell gliadin-dependent agglutination Marco Silano1, Olimpia Vincentini1, Alessandro Luciani2, Cristina Felli1, Sergio Caserta3, Speranza Esposito2, Valeria Rachela Villella3, ...
(2007)02—0288—04 ·论著 · K562和K562/AO2细胞HLAI类分子与MICA/B的 表达及其对NK细胞杀伤活性的影响 梅家转,牛新清,郭坤元,周健,魏红梅 南方医科大学珠江医院血液科,广州510282 摘要 本研究探讨K562亲本细胞株及多药耐药细胞株K562/A02细胞表面HLAI类分子和MHCI类链相关分 子(MICA/B)的表达及其对NK细胞...
Lisovsky I, Isitman G, Bruneau J, Bernard NF. Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells. J Leukoc Biol (2015) 97(4):761-7. doi:10.1189/jlb.4AB1014-499RLisovsky I, Isitman G, Bruneau J, Bernard NF (2015) Func- tional analysis of ...
In Vitro Expansion of Antigen-Specific Cytotoxic T Lymphocytes by HLA-A*0201 Transfected K562 for Monitoring of T-cell Responsesdendritic cellsimmunotherapyserum-free mediumanti-interleukin-10Monocyte-derived dendritic cells (MoDCs) in clinical use for cancer immunotherapy are ideally ...
phenotype and comparable cytotoxicity, CD107a, and interferon-γ (IFN-γ) production. More importantly, our expansion method achieved more than a 10,000-fold expansion of adaptive NK cells after 6 weeks of culture, providing a high yield of alloreactive NK cells for cell therapy against cancer...